NCT05071612Phase 2Completed

Parallel Arm Trial of AD109 and AD504 In Patients With OSA

Study sponsor: Apnimed

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2022-07-20Actual
Enrollment · participants294Actual
Source updated2026-08-12Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Change in AHI, Combined AD109 Dose Arms vs. Combined Placebo Arms. After: Measure: Change in Apnea-Hypopnea Index (AHI4) From Baseline: Combined AD109 Arms vs. Placebo.

Check registry source

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Change in AHI, combined AD109 dose arms vs. combined placebo arms. After: Measure: Change in AHI, Combined AD109 Dose Arms vs. Combined Placebo Arms.

Check registry source